Agaplesion Markus Krankenhaus

Frankfurt am Main, Hesse 60431

1 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Breast Neoplasms, Low Grade Serous Ovarian Cancer, Neoplasm Metastasis

Studies at this site

• A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer — Recruiting now
• A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer — Running, not enrolling
• Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling